Advanced company searchLink opens in new window

YORKDALE PHARMA LIMITED

Company number 13473836

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
09 Apr 2024 CS01 Confirmation statement made on 30 March 2024 with no updates
23 Mar 2024 AA Full accounts made up to 30 June 2023
05 Mar 2024 PSC07 Cessation of Cortex 3 Guernsey Limited as a person with significant control on 22 November 2021
23 Feb 2024 RP04PSC01 Second filing for the notification of Guy Semmens as a person with significant control
18 Jul 2023 AP01 Appointment of Mrs Emma Jane Johnson as a director on 1 July 2023
18 Jul 2023 TM01 Termination of appointment of Steen Vangsgaard as a director on 30 June 2023
30 Mar 2023 CS01 Confirmation statement made on 30 March 2023 with updates
24 Feb 2023 AA Full accounts made up to 30 June 2022
19 Jul 2022 CS01 Confirmation statement made on 22 June 2022 with no updates
18 Jul 2022 RP04AP01 Second filing for the appointment of Mr Andrew Michael Webb as a director
10 May 2022 AP01 Appointment of Mr Andrew Michael Webb as a director on 1 May 2022
  • ANNOTATION Clarification a second filed AP01 was registered on 18/07/2022.
10 May 2022 TM01 Termination of appointment of Ingvild Liborg as a director on 30 April 2022
25 Nov 2021 AD01 Registered office address changed from Rosemont House Yorkdale Industrial Park Braithwaite Street Leeds LS11 9XE England to 8a Crabtree Road Egham Surrey TW20 8RN on 25 November 2021
25 Nov 2021 TM01 Termination of appointment of Howard Langton Taylor as a director on 22 November 2021
25 Nov 2021 TM01 Termination of appointment of Iain Fawcett as a director on 22 November 2021
25 Nov 2021 TM01 Termination of appointment of Timothy Mark Busby as a director on 22 November 2021
25 Nov 2021 AP01 Appointment of Ingvild Liborg as a director on 22 November 2021
25 Nov 2021 AP01 Appointment of Benjamin Matthew Ash as a director on 22 November 2021
25 Nov 2021 AP01 Appointment of Steen Vangsgaard as a director on 22 November 2021
25 Nov 2021 PSC07 Cessation of Rosemont Pharmaceuticals Limited as a person with significant control on 22 November 2021
25 Nov 2021 PSC02 Notification of Cortex 3 Guernsey Limited as a person with significant control on 22 November 2021
25 Nov 2021 PSC01 Notification of Guy Semmens as a person with significant control on 22 November 2021
  • ANNOTATION Clarification a second filed PSC01 was registered on 23/02/2024.
02 Jul 2021 CH01 Director's details changed for Mr Howard Langton Taylor on 23 June 2021
23 Jun 2021 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2021-06-23
  • GBP 1